On Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]
Tahseen Mozaffar, MD, FAAN
Advertisement
Articles by Tahseen Mozaffar, MD, FAAN
The director of the Division of Neuromuscular Diseases at UC Irvine discussed the positive data, noting that the treatment was “incredibly safe.” [WATCH TIME: 4 minutes]
Advertisement
Latest Updated Articles
The Benefits of a New Therapy for Pompe Disease: Tahseen Mozaffar, MD, FAANPublished: February 28th 2022 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Parkinson Agent Tavapadon Shows Continued Efficacy, Safety in Phase 3 TEMPO-4 Trial
2
RWJBarnabas and Rutgers Health Researchers Pursue Advanced Neurostimulation Technology to Treat Epileptic Seizures
3
This Week on NeurologyLive® — October 20, 2025
4
NeurologyLive® Brain Games: October 19, 2025
5
